![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Efficacy and safety of direct-acting antivirals
in children and adolescents with chronic hepatitis
C virus infection: a systematic review and meta-analysis
|
|
|
EASL 2022 June 22-26 London
G. Indolfi1, S. Giometto2, F. Malik3, R. Chou4, P. Easterbrook5, E. Lucenteforte2
1 Department NEUROFARBA, University of Florence and Paediatric and Liver Unit, Meyer Children's University Hospital, Firenze, Italy; 2 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 3 Great Ormond Street Institute of Child Health, University College London, London, United Kingdom; 4 Departments of Medicine, and Medical Informatics & Clinical Epidemiology, Oregon Health Sciences University, Oregon, United States; 5 Global HIV, Hepatitis and STI Programmes, World Health Organization Headquarters, 20 Avenue Appia, Geneva, 1211 Switzerland
![0622221](../images/062222/062222-13/0622221.gif)
![0622222](../images/062222/062222-13/0622222.gif)
![0622223](../images/062222/062222-13/0622223.gif)
![0622224](../images/062222/062222-13/0622224.gif)
![0622225](../images/062222/062222-13/0622225.gif)
![0622226](../images/062222/062222-13/0622226.gif)
![0622227](../images/062222/062222-13/0622227.gif)
![0622228](../images/062222/062222-13/0622228.gif)
![0622229](../images/062222/062222-13/0622229.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|